FDA Inspection 1256232 - Exel Inc. - November 25, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Exel Inc.

Record Details

This FDA Inspection record concerns Exel Inc., with an inspection on November 25, 2024, issued by the Cincinnati District Office, covering human drugs.

Company: Exel Inc.
Inspection Date: November 25, 2024
Product Type: Human Drugs
Office: Cincinnati District Office

Open in Dashboard

ID · 170f6ea8-8426-45d5-a516-c2cc981d3568

Violation Codes7

21 CFR 211.100(a)21 CFR 211.125(f)21 CFR 211.170(b)21 CFR 211.180(e)(2)21 CFR 211.18221 CFR 211.19221 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.